We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wall Street's Insights Into Key Metrics Ahead of Healthpeak (DOC) Q3 Earnings
Read MoreHide Full Article
In its upcoming report, Healthpeak (DOC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.45 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $696.02 million, representing a year-over-year decrease of 0.6%.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Healthpeak metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenues- Interest income and other' reaching $16.28 million. The estimate points to a change of +13.8% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Rental and related revenues' at $534.27 million. The estimate points to a change of -1.7% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenues- Resident fees and services' should arrive at $152.24 million. The estimate points to a change of +6.6% from the year-ago quarter.
Analysts forecast 'Depreciation and amortization' to reach $265.60 million.
Shares of Healthpeak have experienced a change of +1.2% in the past month compared to the +1.2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DOC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Wall Street's Insights Into Key Metrics Ahead of Healthpeak (DOC) Q3 Earnings
In its upcoming report, Healthpeak (DOC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.45 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $696.02 million, representing a year-over-year decrease of 0.6%.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Healthpeak metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenues- Interest income and other' reaching $16.28 million. The estimate points to a change of +13.8% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Rental and related revenues' at $534.27 million. The estimate points to a change of -1.7% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenues- Resident fees and services' should arrive at $152.24 million. The estimate points to a change of +6.6% from the year-ago quarter.
Analysts forecast 'Depreciation and amortization' to reach $265.60 million.
View all Key Company Metrics for Healthpeak here>>>Shares of Healthpeak have experienced a change of +1.2% in the past month compared to the +1.2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DOC is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .